Filing Details
- Accession Number:
- 0000930413-18-003129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-22 09:00:22
- Reporting Period:
- 2018-10-18
- Accepted Time:
- 2018-10-22 09:00:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1694674 | A. Bruce Hanna | C/O Enzo Biochem Inc. 527 Madison Avenue New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-18 | 15,000 | $3.52 | 37,816 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On January 5, 2017, the Reporting Person was granted 41,632 Stock Options (to acquire common stock), half of which (20,816) vested on January 6, 2018.
Billionaire Hedge Funds
